Giovanna Manzi | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
The Early Pharmacological Strategy with Inodilator, bEta-blockers, Mineralocorticoid Receptor Antagonists, Sodium-glucose coTransporter-2 Inhibitors and Angiotensin Receptor-neprylisin Inhibitors in Acute Heart Failure (PENTA-HF)	CURRENT VASCULAR PHARMACOLOGY	2025
Right ventricular/pulmonary artery coupling in patients with heart failure with preserved ejection fraction. a clue for pulmonary hypertension	JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE	2024
Strategy for an early simultaneous introduction of four-pillars of heart failure therapy: results from a single center experience	AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS	2024
SGLT2i effect on atrial fibrillation: A network meta-analysis of randomized controlled trials	JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY	2024
Prognostic assessment of hlm score in heart failure due to ischemic heart disease. a pilot study	JOURNAL OF CLINICAL MEDICINE	2024
Biobanks: The unmet need in heart failure management	VASCULAR PHARMACOLOGY	2023
Medical Management of Right Ventricular Dysfunction in Pulmonary Arterial Hypertension	CURRENT HEART FAILURE REPORTS	2023
Impact of parenteral prostanoids in pulmonary arterial hypertension. the relevance of timing	JOURNAL OF CLINICAL MEDICINE	2023
Comparative effectiveness of oral therapies targeting the prostacyclin pathway in pulmonary arterial hypertension: A systematic review and network meta-analysis	INTERNATIONAL JOURNAL OF CARDIOLOGY	2023
Computational simulator models and invasive hemodynamic monitoring as tools for precision medicine in pulmonary arterial hypertension	JOURNAL OF CLINICAL MEDICINE	2022
The paradox of pulmonary arterial hypertension in Italy in the COVID-19 era: is risk of disease progression around the corner?	EUROPEAN RESPIRATORY JOURNAL	2022
Future perspective in diabetic patients with pre- and post-capillary pulmonary hypertension	HEART FAILURE REVIEWS	2022
Incremental value of cardiopulmonary exercise testing in intermediate-risk pulmonary arterial hypertension	THE JOURNAL OF HEART AND LUNG TRANSPLANTATION	2022
Telehealth. a winning weapon to face the COVID-19 outbreak for patients with pulmonary arterial hypertension	VASCULAR PHARMACOLOGY	2022
Gaps of evidence in pulmonary arterial hypertension	INTERNATIONAL JOURNAL OF CARDIOLOGY	2022
Comment on Topyła-Putowska et al. Echocardiography in Pulmonary Arterial Hypertension: Comprehensive Evaluation and Technical Considerations. J. Clin. Med. 2021, 10, 3229	JOURNAL OF CLINICAL MEDICINE	2022
Pulmonary pressure recovery in idiopathic, hereditary and drug and toxin-induced pulmonary arterial hypertension: determinants and clinical impact	VASCULAR PHARMACOLOGY	2022
Phenotypes of idiopathic pulmonary arterial hypertension	THE LANCET RESPIRATORY MEDICINE	2022
Relevance of comorbidities on initial combination therapy in pulmonary arterial hypertension	ERJ OPEN RESEARCH	2022
Impact of non-cardiac comorbidities on diastolic properties in HFREF and HFmrEF patients	EUROPEAN HEART JOURNAL SUPPLEMENTS	2022